Playbook
Getting to 'Yes' with FDA
Embarking on a life science startup journey means facing a complex set of rules and regulations that could make or break your venture. In this playbook, trailblazing experts in the field lay out a roadmap for navigating the regulatory landscape.
Key Lessons From This Playbook
Overengineering can wait: Gather insights from all stakeholders and build only what’s essential. Keep it simple, and consider FDA from the start—overengineering can weigh you down more than lift you up.
Involve the right regulatory experts early: Ensure compliance by seeking domain expertise from the start. But remember, while subject matter experts are valuable, rigid, one-size-fits-all strategies may not suit every project.
Balance risk with tradition: In regulatory work, experience and expertise are invaluable, but so is the ability to think outside the box. You get the best of both worlds by hiring a team that balances seasoned pros with creative thinkers who can push boundaries and find creative solutions.
Keep an open dialogue: Think of the FDA as a partner in bringing your technology to patients—initiate contact early, keep communication lines open, and be prepared to adapt your strategy as the regulatory landscape shifts.
Educate when necessary: Work closely with regulators early on and be ready to educate them about the nuanced aspects of your technology—especially when you’re breaking new ground.